Select your country SOLUTIONS KNOWLEDGE ABOUT Convenience & Peace Of Mind From Using VAXXITEK® HVT + IBD CONVENIENCE & PEACE OF MIND FROM USING VAXXITEK® HVT + IBD VAXXITEK HVT + IBD was specifically designed to overcome some of the complexities of infectious bursal disease (IBD) vaccination, by reducing labor in the field and offering a simpler, more straightforward vaccination protocol. Here's how... FEWER CHOICES FOR A SIMPLIFIED APPROACH No need for separate vaccines for IBD and for the HVT component of a vaccination program against Marek's disease—VAXXITEK HVT + IBD offers both in one product No need to define multiple vaccination dates—it's a single injection, on a pre-defined day Published research supports VAXXITEK HVT + IBD as a highly-effective choice against IBD—in 100+ scientific papers published to date (see all) it induced protection against many different classic, variant, and very virulent IBD strains found worldwide* A SIMPLE, STRAIGHTFORWARD VACCINATION PROTOCOL Thanks to its underlying technology and mode of action, VAXXITEK HVT + IBD does not require measuring of maternal antibodies or calculating vaccination dates: vaccination happens at the hatchery, on a set schedule, initiating early* protection against IBD and certain variants of Marek's disease. Once birds arrive on the farm, vaccination tasks related to these diseases are generally behind you. THE PEACE OF MIND THAT COMES WITH HATCHERY VACCINATION By moving IBD vaccination from the farm to the hatchery, VAXXITEK HVT + IBD brings many advantages: A controlled vaccination environment with a high level of biosecurity Individual bird dosing for flock-wide accuracy and uniformity Early* protection; published research has demonstrated a reduced opportunity for an immunity gap as maternal antibodies decline11-12, 18-19 Less labor on the farm, and a lower risk of inappropriate vaccine handling during field use Less stress on growing birds No quality or accuracy concerns associated with drinking water or spray techniques FLEXIBILITY OF ADMINISTRATION: TWO HATCHERY OPTIONS In-ovo at 18-19 days of incubation Subcutaneously in healthy day-old chicks Whichever mode you choose, Boehringer Ingelheim's industry-leading Vaccination Technologies and Services (VTS) group provides state-of-the-art vaccination equipment, plus on-site training and ongoing support to ensure your successful use of VAXXITEK HVT + IBD. Not yet prepared at the hatchery? No problem—our VTS teams can assess your current operations and develop an actionable, cost-effective plan for making the transition. ADDITIONAL RESOURCES Efficacy, Safety, & Health Benefits of Disease Reduction The Technology Behind VAXXITEK® HVT + IBD Our vaccination Equipment, Supplies, & Related Services Our vaccination Training & Technical Support Audits, Quality Control, & On-Site Consulting REFERENCED PUBLICATIONS VIEW ALL INFO Solutions Knowledge About Events Legal Notifications Privacy CONNECT ©2017 Merial. All rights reserved. VAXXITEK is a registered trademark of Merial in the United States of America and elsewhere. Merial is now part of Boehringer Ingelheim. BACK TO TOP